Company News

Stay up to date on the exciting events that happen with Tower MSA and our industry.

High-Risk Opioid Abuse Is Just As High In Prescribed Users

Posted on March 27, 2014 by Rita Wilson

In this JAMA research letter findings show that doctor prescribed opioids cause over-doses just as much, if not more, as non-medical use of prescription pain medicine. People who are at the greatest risk for abuse are those being prescribed pain…

Read more

FDA Approves Long-Lasting Narcotic – Oxycodone / Acetaminophen

Posted on March 19, 2014 by Rita Wilson

The first FDA approved long-acting combination of narcotic analgesic oxycodone with acetaminophen is now available for pain management. It will be manufactured by Mallinckrodt and is a single strength tablet to be dosed twice daily. This new form of pain…

Read more

Zohydro – Promised Relief or One More Opioid in the Spiral of Addiction?

Posted on March 5, 2014 by Rita Wilson

When Zogenix announced on October 25, 2013 that the U.S. Food and Drug Administration (FDA) had approved ZohydroTM ER (hydrocodone bitartrate) extended-release capsules,  an extended-release oral formulation of hydrocodone without acetaminophen, the announcement came with the promise of continuous relief in the management…

Read more

For Media Inquires, Contact:

Helen King Patterson

    Subscribe to our blog & news

    Search our blog:

    Contact Us for a FREE Consultation